| Report ID | 281009 |
| Drug Identification Number | 02500736 |
| Brand name | MORPHINE SULFATE INJECTION |
| Common or Proper name | Morphine Sulfate Injection |
| Company Name | JAMP PHARMA CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | MORPHINE SULFATE |
| Strength(s) | 15MG |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR |
| Packaging size | 10 ampoules x 1 mL |
| ATC code | N02AA |
| ATC description | OPIOIDS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2026-03-12 |
| Estimated end date | 2026-03-27 |
| Actual end date | 2026-03-27 |
| Shortage status | Resolved |
| Updated date | 2026-03-27 |
| Company comments | Short dates available |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2026-03-27 | French | Compare |
| v5 | 2026-03-27 | English | Compare |
| v4 | 2026-03-20 | French | Compare |
| v3 | 2026-03-20 | English | Compare |
| v2 | 2026-03-20 | French | Compare |
| v1 | 2026-03-20 | English | Compare |
Showing 1 to 6 of 6